Autonomize AI
Nishi Viswanathan, MD, MBA, serves as the Vice President of Product, Commercialization & Business Development at Innovation Lab, where product management and business development efforts are focused on medical technology. Nishi is also the Chief Executive Officer of LiveBand BFR, a venture aimed at advancing Blood Flow Restriction technology for rehabilitation. Additionally, advisory roles include contributions to Autonomize Inc, Noleus Technologies, and SWAN Impact Network, along with board membership at the Texas Suicide Prevention Collaborative. Nishi holds positions as an Adjunct Faculty Member at The University of Texas at Austin and as Chief Innovation Advisor for The Milburn Foundation. Nishi's extensive experience in health product innovation includes leadership at Texas Health Catalyst, guiding numerous early-stage technologies towards commercialization. Academic credentials comprise an MBA from Texas McCombs School of Business, a Master's in Nutrition & Cancer Signaling from The University of Texas at Austin, and an MBBS from GS Medical College/KEM Hospital.
This person is not in any teams
This person is not in any offices
Autonomize AI
1 followers
Autonomize’s AI copilots organize, contextualize and summarize unstructured data to reduce the administrative burden for healthcare knowledge workers to make data-driven decisions and improve patient outcomes. Autonomize AI is a founding member of CancerX, the US President Biden’s Cancer Moonshot initiative. Our customers include Top 20 pharma, F100 Payors and life sciences companies.